Article Details
Retrieved on: 2019-02-27 09:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Vanguard Group</b> Inc boosted its holdings in Syros Pharmaceuticals Inc (NASDAQ:SYRS) by 4.4% during the third quarter, according to its most recent ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here